J 2015

Anti-Gal IgM, IgA and IgG Natural Antibodies in Childhood

HAMANOVÁ, Markéta, Magda CHMELÍKOVÁ, Ivo NENTWICH, Vojtěch THON, Jindřich LOKAJ et. al.

Basic information

Original name

Anti-Gal IgM, IgA and IgG Natural Antibodies in Childhood

Authors

HAMANOVÁ, Markéta (203 Czech Republic, belonging to the institution), Magda CHMELÍKOVÁ (203 Czech Republic, belonging to the institution), Ivo NENTWICH (203 Czech Republic), Vojtěch THON (203 Czech Republic, guarantor, belonging to the institution) and Jindřich LOKAJ (203 Czech Republic, belonging to the institution)

Edition

Immunology Letters, Amsterdam, Elsevier, 2015, 0165-2478

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.483

RIV identification code

RIV/00216224:14110/15:00082841

Organization unit

Faculty of Medicine

UT WoS

000351801500006

Keywords in English

Anti-Gal; Childhood; Immunodeficiency; Kinetics; Natural antibodies

Tags

Tags

International impact, Reviewed
Změněno: 28/8/2015 14:33, Soňa Böhmová

Abstract

V originále

The target for the most abundant xenoreactive natural antibodies in humans is the a-Gal epitope. Anti-Gal could provide natural immune defense against pathogens that express the a-Gal epitope. Anti-Gal natural antibodies are usually studied in adult individuals. Data demonstrating the incidence and concentration of anti-Gal natural antibodies in childhood are in short supply and incomplete. In the present study we prospectively quantified anti-Gal IgM, IgA and IgG levels in different age groups of children from delivery to 24 months of age and compared these levels to the level of these antibodies in their respective mothers. Measurement of anti-Gal antibodies may broaden the spectrum of specific antibodies that are available for determination of specific antibody responses in physiological and pathological conditions in children. Plasma was collected from umbilical cord blood of full term newborn, from blood of infants at age 6, 12 and 24 months and from their respective mothers at time of delivery. Quantitative determination of anti-Gal antibodies IgM, IgA and IgG were made with the enzyme immunoassays Human Anti-Alpha Galactosyl IgM ELISA, IgG ELISA and IgA ELISA. Hemagglutination activity was titrated against rabbit erythrocytes. The kinetic processes for the formation of natural antibodies in the first two years of life, in general, compared with the kinetics for the formation of total immunoglobulins IgM, IgA and IgG. There were no detectable anti-Gal IgM and IgA in the cord blood, whereas anti-Gal IgG were found at similar levels in both neonate cord blood and peripheral blood of their respective mothers. When comparing the percentage of natural antibodies in the plasma of children, the level of natural antibodies in children at the age of two years was approximately 37% for IgM, 25% for IgG and 15% for IgA. The titration of antibodies required for agglutination of rabbit red blood cells over the 24 month period followed the same trend observed for the formation of natural antibodies. Our study demonstrates the kinetics of formation of anti-Gal IgM, IgA and IgG natural antibodies in the first two years of life. The relative lack of these antibodies in this period should be taken into account when assessing for humoral immunodeficiencies, particularly with regards to the potential for children to mount an anti-carbohydrate response.

Links

7E08062, research and development project
Name: Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
Investor: Ministry of Education, Youth and Sports of the CR, Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes